CE23-002 - Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City
CE23-002 - Assessing the Impact of Overdose Prevention Centers as a Polysubstance Use and Behavioral Health Intervention in New York City
批准号:
10783253
负责人:
Bennett Allen
金额:
$15.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2026-09-29
中文摘要
项目总结/摘要
在美国,药物过量的流行仍然有增无减。毒品供应的变化和
与兴奋剂有关的过量死亡已经将阿片类药物过量流行病转变为多种物质
吸毒过量的流行病现在全国超过一半的过量死亡涉及多种物质,导致一些
研究人员将目前的多物质时代确定为流行病的“第四波”。多种物质增加
使用(PSU)和PSU过量给从业者和研究人员带来了许多挑战。知道
新出现的减少伤害干预措施是否以及在多大程度上可以减少PSU涉及的过量风险,
对公共卫生当局和服务提供者至关重要。过量预防中心(OPCs),社区-
个人在受过培训的监督下消费预先获得的受控物质的设施
在发生药物过量的情况下能够进行干预的工作人员就是这样一种干预。全球有200多家OPCs运营,
2021年,美国首批两家公开认可的OPC在纽约市开业。OPCs其他
国家与减少致命和非致命过量风险和减少紧急服务有关
利用率然而,先前的研究尚未评估OPC使用对PSU过量风险的影响-
涉及人口。此外,并发精神健康障碍仍然是一个关键但未充分探讨的风险
PSU过量和其他危害的因素,但迄今为止的研究尚未评估OPC之间的关联
使用和心理健康结果,尽管估计表明,
OPC客户端因此,本K 01提案的目标是解决这些关键的研究差距,以:(1)确定
OPC使用对参与PSU的个体的非致命性和致命性过量风险的异质性影响;(2)
估计OPC使用对PSU患者治疗精神病事件的影响;(3)评估需求
减少伤害提供者将心理健康服务整合到现有的注射器服务和OPC服务中
模式,特别注重涉及PSU的人口的需求。该研究计划得到了
优秀的导师团队和培训计划。拟议的项目建立在候选人的背景,
药物使用流行病学和数据科学,并在几个领域提供新的培训:(1)新的统计
确定OPC使用对PSU中过量风险的异质性治疗效应的方法-
涉及的个人;(2)精神病流行病学和心理健康之间的复杂关系,
物质使用障碍和PSU;(3)实施科学,概念化和评估新的
为PSU相关人群提供综合行为健康护理模式。联合研究和培训
该计划将使候选人过渡到政策相关的社会和
行为因素决定了过量用药的风险这项研究与CDC的过量预防研究一致
优先确定PSU过量风险和社会生态多个层面的保护因素。
英文摘要
PROJECT SUMMARY/ABSTRACT
The overdose epidemic continues unabated in the United States. Changes to the drug supply and increases in
stimulant-involved overdose deaths have shifted what was an opioid overdose epidemic to a polysubstance
overdose epidemic. Over half of overdose deaths nationally now involve multiple substances, leading some
researchers to identify the current polysubstance era as the epidemic’s “fourth wave.” Increases in polysubstance
use (PSU) and PSU overdose pose a host of challenges for practitioners and researchers to address. Knowing
whether and to what extent emerging harm reduction interventions can reduce PSU-involved overdose risk is
critical for public health authorities and service providers. Overdose prevention centers (OPCs), community-
based facilities at which individuals consume pre-obtained controlled substances under the supervision of trained
staff who can intervene in event of an overdose, are one such intervention. Over 200 OPCs operate globally, but
the first two publicly recognized OPCs in the United States opened in New York City in 2021. OPCs in other
countries are associated with reduced fatal and non-fatal overdose risk and reduced emergency service
utilization. However, prior research has not assessed the impact of OPC use on overdose risk among PSU-
involved populations. In addition, concurrent mental health disorders remain a critical yet underexplored risk
factor for PSU overdose and other harms, yet studies to date have not assessed the association between OPC
use and mental health outcomes, despite estimates suggesting a high untreated mental health burden among
OPC clients. As such, the objective of this K01 proposal is to address these critical research gaps to: (1) identify
heterogeneous impacts of OPC use on non-fatal and fatal overdose risk among individuals engaging in PSU; (2)
estimate the impact of OPC use on treated psychiatric events among clients with PSU; and (3) assess the needs
of harm reduction providers to integrate mental health services into existing syringe service and OPC delivery
models, with a particular focus on the needs of PSU-involved populations. The research plan is bolstered by an
exceptional mentorship team and training plan. The proposed project builds on the candidate’s background in
substance use epidemiology and data science and provides new training in several areas: (1) novel statistical
methods for the identification of heterogeneous treatment effects of OPC use on overdose risk among PSU-
involved individuals; (2) psychiatric epidemiology and the complex relationship between mental health,
substance use disorders, and PSU; and (3) implementation science to conceptualize and evaluate novel
integrated behavioral health care models for PSU-involved populations. The combined research and training
plan will enable the candidate to transition into an independent researcher of policy-relevant social and
behavioral factors that shape overdose risk. This research aligns with CDC’s Overdose Prevention Research
Priorities to identify PSU overdose risk and protective factors across multiple levels of the social ecology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Zn(002)晶面锌合金负极制备/运行稳定化全流程设计及机制研究
-
批准号:22578113
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:何章兴
-
依托单位:
锌粉(002)晶面定向调控及其负极性能强化机理研究
-
批准号:2025JJ70625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹鹏辉
-
依托单位:
Uc002jit.1调控DNA损伤修复诱导AML干细胞化疗耐药的机制及干预策略研究
-
批准号:82404736
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:李丁
-
依托单位:
新型核素偶联药载体JBN002-DOTA的开发及其在肿瘤诊疗中的应用
-
批准号:82373174
-
项目类别:面上项目
-
资助金额:60万元
-
批准年份:2023
-
负责人:杨杰
-
依托单位:
tiRNA-Val-CAC-002介导ITGB3/PI3K/Akt调控FB自噬促进OSF发生机制研究
-
批准号:2023JJ30946
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴颖芳
-
依托单位:
双胍新衍生物SMK-002阻断PKM2入核下调脂质合成抑制EMT阻止膀胱癌转移的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:杨小平
-
依托单位:
tiRNA-Gly-GCC-002 调控FKBP5 在狼疮性肾炎肾小管上皮细胞损伤中的作用及机制研究
-
批准号:LY22H050004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈朝生
-
依托单位:
关键挥发性有机物介导根际促生菌NRCB002定殖的根际生物学机制
-
批准号:32172673
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:高南
-
依托单位:
(002)取向石墨化碳材料的制备及其储钾性能
-
批准号:22075268
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2020
-
负责人:林宁
-
依托单位:
外泌体lncRNAuc002ktr.3在肺鳞癌顺铂耐药中的作用及其作为新型耐药标志物的临床价值
-
批准号:81972006
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:王保龙
-
依托单位: